Latin America’s Embrace of an Unproven COVID Treatment Is Hindering Drug Trials
October 20, 2020
(Nature) – As much of the world waits for an effective vaccine to curb the COVID-19 pandemic, some in Latin America are turning to an unproven treatment. There isn’t enough evidence that the drug, ivermectin, is safe or effective as a coronavirus therapy, however. So researchers are cautioning against using it outside clinical trials. Still, people in the region have rushed to take it, making it hard for researchers to properly test it.